“Don’t let the world around you squeeze you into its own mould, but let God re-mould your minds from within...”
Romans 12:2

No one logged in. Log in

Hilary's Desk

FDA questioned about genetically engineered HPV DNA in Gardasil worldwide.

Hilary Butler - Monday, September 05, 2011

All New Zealand samples contaminated.


A few days ago, an American organisation put on their website a copy of a letter sent to the FDA, in which they stated that thirteen samples of Gardasil from Poland, France, Spain, USA, New Zealand and Australiamade in four different Merck factories (USA, Holland, France and CSL Australia) had been tested, and found to contain genetically engineered dna fragments which the purification process failed to remove.  Yesterday, a more detailed press release was put onto SANE-Vax's site, which showed samples contaminated with HPV DNA 11 and 18.  The New Zealand results can be seen here.

One of the genetically engineered particles found is said to be  a genetically engineered syntheticaly constructed gene designed to instruct the yeast or baculovirus cells, to make the HPV-11 outer capsid protein (virus-like particles) for the Gardasil vaccine.  

This is the Pubmed site for GenBank Locus SCU55993, which is the picture below, of ONE of the alleged contaminants:




Wavy lines mean nothing to me, and probably nothing to you.  

SANE-vax's letter doesn't specifically say what the other contaminants are, but say that the rest of their proof is available for review provided that FDA provides " appropriate safeguards ... to protect the proprietary processes and information utilized by our laboratory to test the samples."

To me, no platitudes and fob-offs on this issue are acceptable.

The first question that comes to mind is,

"Is  this  a  big  deal?"


This isn't a quality issue in one factory.

The problem, according to the testing done by SANE-vax shows;

A global manufacturing fault.

 

A global manufacturing issue relating to vaccine design, process and purity - IS - a big deal.

The next question is:

Are  the  "genetically  altered  HPV  DNA  fragments"  a  big  deal?

 Read Full Blog

An insurance policy to the Global Immunization Agenda against Rotaviruses

Hilary Butler - Wednesday, May 12, 2010

It makes logical sense that very high IgA levels of rotavirus neutralizing antibodies in breast-milk, would result in babies not developing high levels of antibodies against an oral rotavirus vaccine, right? The conclusions of a recent study was that lots of studies should look at stopping mothers breastfeeding before and after vaccination, to overcome this "negative effect”.   Read Full Blog